Legend Biotech(LEGN) - 2024 Q2 - Quarterly Report
Legend Biotech(LEGN)2024-08-09 11:01UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________ FORM 6-K ________________________________ Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Date of Report: August 9, 2024 Commission File Number: 001-39307 ________________________________ | --- | |-----------------------------------------------------------------------------------------| | | | | | (Exact Name of Registrant as Specified in its Chart ...